MS Briefs

Increased Incidence of Myocardial Infarction in MS

Neurology; ePub 2019 Mar 6; Marrie, et al


 

In patients with multiple sclerosis (MS), the risk of acute myocardial infarction (AMI) is elevated but may not be accounted for by traditional vascular risk factors, a new study found. Researchers conducted a retrospective matched cohort study using population-based administrative data in 2 Canadian provinces. Incident MS cases were identified and for each case, up to 5 controls without MS were matched on age, sex, and region. The incidence of AMI between cohorts was compared using incidence rate ratios (IRRs). Among the findings:

  • 14,565 persons with MS and 72,825 matched controls were identified.
  • The crude incidence of AMI per 100,000 population was 146.2 in the MS population vs 128.8 in the matched population.
  • After age standardization, the incidence of AMI was higher in the MS population vs the matched population (IRR 1.18).
  • After adjustment, the hazard of AMI was 60% higher in the MS population vs the matched population (hazard ratio 1.63).

Marrie RA, Garland A, Schaffer SA. Traditional risk factors may not explain increased incidence of myocardial infarction in MS. [Published online ahead of print March 6, 2019]. Neurology. doi: 10.1212/WNL.0000000000007251.

Recommended Reading

New data bolster latitude’s association with MS prevalence
ICYMI Multiple Sclerosis
Optical coherence tomography emerging as a promising biomarker for MS
ICYMI Multiple Sclerosis
Study eyes serious adverse events from long-term rituximab use in MS
ICYMI Multiple Sclerosis
Smartphone technology helps to detect, track eye changes in MS
ICYMI Multiple Sclerosis
Expert calls for more ‘ethnocentric’ research in MS
ICYMI Multiple Sclerosis
Interview with John Corboy, MD, on discontinuing disease modifying therapy in elderly patients with MS
ICYMI Multiple Sclerosis
Study launched to further evaluate the central vein sign in MS
ICYMI Multiple Sclerosis
MS researchers aim to build MRI diagnostic portfolio beyond the central vein sign
ICYMI Multiple Sclerosis
30-Day Readmissions in Multiple Sclerosis
ICYMI Multiple Sclerosis
Risk Tolerance in MS Therapies
ICYMI Multiple Sclerosis